SBTX.L Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 18:27):

SkinBioTherapeutics plc, a life science company, engages in the research and development of technology that harnesses the human microbiome to improve health...

Stats
Dzisiejszy wolumen	281 658
Średni wolumen	715 946
Kapitalizacja rynkowa	18.54M
EPS	£0 ( 2024-03-25 )
Last Dividend	£0 ( N/A )
Next Dividend	£0 ( N/A )
P/E	-4.62
ATR14	£0.225 (2.50%)

SkinBioTherapeutics PLC Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

SkinBioTherapeutics PLC Finanse

Annual	2022
Przychody:	£132 057
Zysk brutto:	£41 653.00 (31.54 %)
EPS:	£-0.0172

FY	2022
Przychody:	£132 057
Zysk brutto:	£41 653.00 (31.54 %)
EPS:	£-0.0172

FY	2022
Przychody:	£74 761.00
Zysk brutto:	£45 337.00 (60.64 %)
EPS:	£-0.0161

FY	2021
Przychody:	£0.00
Zysk brutto:	£0.00 (0.00 %)
EPS:	£-0.0112

Financial Reports:

No articles found.

SkinBioTherapeutics PLC

SkinBioTherapeutics plc, a life science company, engages in the research and development of technology that harnesses the human microbiome to improve health. The company develops SkinBiotix technology that can enhance the barrier effect of skin models, protect skin from infections, and repair wounds; and AxisBiotix that focuses on the gut-skin relationship and is designed to alleviate the symptoms associated with psoriasis. It serves cosmetic skincare, food supplements, medical skin care, infection control, and pharmaceutical skincare markets. The company has a collaboration agreement with Croda Plc; the University of Manchester to develop immune-supporting microbiome formulations; and Winclove Probiotics B.V. for the development of a probiotic blend of good bacterial strains based on the modifying properties of specific bacterial species in known psoriasis pathways. The company was formerly known as Skinbiotix Ltd and changed its name to SkinBioTherapeutics plc in December 2016. SkinBioTherapeutics plc was incorporated in 2015 and is based in Newcastle upon Tyne, the United Kingdom.